A single low dose of esketamine after childbirth reduces depressive episodes at 42 days postpartum among mothers with prenatal depression,…
A clinical trial found that administering a single low-dose injection of esketamine immediately after childbirth significantly reduces major depressive episodes…
Study designThis randomised, double blind, placebo controlled trial with two parallel arms was conducted in five tertiary care hospitals across…
This website uses cookies.